RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GAIDANO G
Collezione ASL Biella

Items : 16

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Vitolo U; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Zanni M; Ghiggi C; Liberati AM; Bruna R; Celli M; Annibali O; Cabras MG; Orsucci L; Tani M; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Sassone M; Botto B; Ferreri AJM; Stathis A; Chiappella A; Conconi A; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Biella

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment. in Haematologica / Haematologica. 2020 Nov 1;105(11):2592-2597. doi: 10.3324/haematol.2019.237990.

2020
ASL Biella

Zucca E; Johnson PW; Cavalli F; Lopez Guillermo A; Raderer M; Gaidano G; Margiotta Casaluci G; Kiesewetter B; Torri V; Cascione L; Conconi A; Thieblemont C;

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.

2019
ASL Biella
AOU Novara

Zucca E; Gaidano G; Stathis A; Rossi D; Moccia AA; Moia R; Pirosa MC; Nassi L; Winkler J; Cascione L; Margiotta Casaluci G; Conconi A; Vannata B;

Early progression of disease (POD24) as survival predictor in MALT lymphoma in Journal of Clinical Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez-Guillermo A; Johnson PWM; Zucca E;

Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions. in Hematological oncology / Hematol Oncol. 2018 Feb;36(1):84-92. doi: 10.1002/hon.2447. Epub 2017 Jun 16.

2018
ASL Biella

Gaidano G; Zucca E; Pinotti G; Hitz F; Stathis A; Aprile von Hohenstaufen K; Iacoboni G; Margiotta-Casaluci G; Cascione L; Diem S; Conconi A; Moccia AA; Gulden-Sala W; Gobba S;

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. in Hematological oncology / Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.

2018
ASL Biella
AOU Novara

Cavalli F; Gaidano G; Bertoni F; Bernasconi E; Nassi L; Kwee I; Dirnhofer S; Schmid P; Scherrer A; Staehelin C; Novak U; Battegay M; Hasse B; Darling K; Margiotta-Casaluci G; Conconi A; Zucca E;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere

2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara

Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...

A MALT lymphoma prognostic index. in Blood / Blood. 2017 Sep 21;130(12):1409-1417. doi: 10.1182/blood-2017-03-771915. Epub 2017 Jul 18.

2017
ASL Biella

Zucca E; Torri V; Cavalli F; Johnson PW; Lopez Guillermo A; Coiffier B; Laszlo D; Martelli M; Gaidano G; Kiesewetter B; Raderer M; Conconi A; Cascione L; Thieblemont C;

Rate and causes of 5-azacytidine discontinuation and subsequent therapeutic options in 418 MDS patients from the Italian MDS registry of fondazione Italiana sindromi mielodisplastiche (FISM) in Haematologica

2017
ASL Biella
ASL Torino 5
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mezzabotta M; Conconi AR; Cametti G; Freilone R; Calzamiglia T; Cavaliere M; Gaidano V; Cilloni D; Danise P; Selleri C; Aguzzi C; Finelli C; Poloni A; Allione B; Di Tucci AA; Miglino M; Balleari E; Monagheddu C; Ceccarelli M; Gioia D; Clavio M; Santini V; Gaidano G; Pane F; Angelucci E; Levis A; Goretti R; Musto P;

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). in The oncologist / Oncologist. 2015 Oct;20(10):1149-53. doi: 10.1634/theoncologist.2015-0180. Epub 2015 Aug 12.

2015
ASL Biella

Nowakowski GS; Cavalli F; Habermann TM; Ristow K; Mazzucchelli L; Campo E; Jack A; Pileri SA; Copie-Bergman C; McPhail ED; Thieblemont C; Martinelli G; Martelli M; Johnson PW; Lopez Guillermo A; Gaidano G; Cortelazzo S; Conconi A; Porro E; Pangalis GA; Stathis A; Kalpadakis C; Mian M; Zucca E; Jackson AE;

Life expectancy of young adults with follicular lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2317-22. doi: 10.1093/annonc/mdv376. Epub 2015 Sep 11.

2015
ASL Biella
AOU Novara

Zucca E; Ghielmini M; Montserrat E; Lister TA; Gribben J; Cavalli F; Gaidano G; Rancoita PM; Moccia A; Bertoni F; Matthews J; Franceschetti S; Coutinho R; Lobetti-Bodoni C; Montoto S; Lopez-Guillermo A; Conconi A;

Histologic transformation in marginal zone lymphomas†. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2329-35. doi: 10.1093/annonc/mdv368. Epub 2015 Sep 23.

2015
ASL Biella
AOU Novara

Gaidano G; Zucca E; Ramponi A; Mazzucchelli L; Cavalli F; Stathis A; Moccia AA; Bertoni F; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Conconi A; Franceschetti S;

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.

2014
ASL Biella
AOU Novara

Zucca E; Cavalli F; Gaidano G; Stathis A; Porro E; Kiesewetter B; Vitolo U; Martinelli G; Zinzani PL; Arcaini L; Magagnoli M; Ferreri AJ; Devizzi L; Conconi A; Raderer M; Franceschetti S;